Separate promoters from proximal and medial control regions contribute to the natural killer cell-specific transcription of the human FcgammaRIII-A (CD16-A) receptor gene.

The Journal of Biological Chemistry
J E GessnerR E Schmidt

Abstract

The molecular events governing the differentiation pathway of natural killer (NK) cells are not well understood. The phenotype of mature NK cells is specified by the expression of the low affinity Fc receptor for IgG (human FcgammaRIII, CD16) encoded by the FcgammaRIII-A gene. Here we report that the Pprox promoter (-198/-10) of FcgammaRIII-A stimulated by its own intron enhancer (+10/+712) was only one of the cis-elements that target the expression of a reporter gene in the immature NK cell line, YT. The transcription start sites of the FcgammaRIII-A a2/3 and a5/6 splice alternatives in NK cells were mapped to the medial -1817/-850 FcgammaRIII-A control region. Two promoters, Pmed1 (-942/-850) and Pmed2 (-1376/-1123) resided in this region and controlled for the initiation of these transcript classes encoding the known FcgammaRIII-A receptor protein. Deletion mapping studies demonstrated that the 93 base pairs -942/-850 Pmed1 sequence was sufficient to confer cell type-specific expression in YT cells. The 5' end of Pmed1 (-942 to -921) was required for full promoter function indicating the presence of an important sequence motif recognized by a YT-specific factor. Our data suggest that this motif might be a useful tool for sub...Continue Reading

References

Jun 1, 1992·European Journal of Immunology·P UciechowskiR E Schmidt
Apr 1, 1991·European Journal of Immunology·J H PhillipsL L Lanier
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P AndersonS F Schlossman
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G A PeltzK W Moore
Nov 16, 1995·Nature·J E Gumperz, P Parham
Dec 1, 1993·Immunology Today·H C CleversK Georgopoulos
May 1, 1993·Immunology Today·J G van de Winkel, P J Capel
Mar 1, 1996·The Journal of Experimental Medicine·M LiJ V Ravetch

❮ Previous
Next ❯

Citations

Oct 1, 1998·European Journal of Immunology·P UciechowskiH H Radeke
Mar 28, 2003·BMC Immunology·Ronald D MathisonRichard C Woodman
Dec 13, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aaron R VictorMichael A Caligiuri
Apr 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·N ChouchakovaJ E Gessner
Mar 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Frank HeusohnJ Engelbert Gessner
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Brian T WilhelmDixie L Mager
Feb 2, 2002·Chemico-biological Interactions·Margaret M WhalenFrank Hatcher

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.